Lannett To Close And Sell NY Liquids Plant As Part Of Restructuring Plans
Cost Savings Of $20m Annually Targeted; Portfolio Also Rationalized
Lannett is once again taking the axe to its operations in order to tighten its focus and save on costs, including the planned divestment of its liquids generics manufacturing facility in Carmel, New York.
